Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.

Journal of lipid research - 1 Sept 1997

Kronenberg F, Trenkwalder E, Lingenhel A, Friedrich G, Lhotta K, Schober M, Moes N, König P, Utermann G, Dieplinger H

Abstract excerpt

High plasma concentrations of lipoprotein[a] (Lp[a]) are considered a genetically determined risk factor for atherosclerosis. Lp[a] is produced by the liver. The site(s) and mechanism(s) of catabolism are presently unclear. Lp[a] is elevated secondary to end-stage renal disease which suggests a direct or indirect role of the kidney in the metabolism of Lp[a]. We therefore investigated, by a simple in vivo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aorta

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Arteriosclerosis

Share to Kidney

Share to Kringles

Share to Lipoprotein(a)

Share to Molecular Weight

Share to Phenotype

Source

Identifiers

PMID: 9323585

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.PMID 9323585Read ↗

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).Semantic proximity Read ↗

Lipoprotein(a): new insights into an atherogenic lipoprotein.Semantic proximity Read ↗

Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).Semantic proximity Read ↗

Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.Semantic proximity Read ↗

In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.Semantic proximity Read ↗

[Lipoprotein (a)].Semantic proximity Read ↗

The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.Semantic proximity Read ↗

Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.Semantic proximity Read ↗

The atherogenic lipoprotein phenotype in renal diseaseSemantic proximity Read ↗

Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.Semantic proximity Read ↗

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Semantic proximity Read ↗

Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.